IL6 and diabetic kidney disease: (TC-PLA NPs) exerted renal protective effects in STZ-induced diabetic nephropathy rats by reducing the expression of inflammatory factors (TNF-α, IL-6) and stabilizing renal function indicators (Scr, BUN) [64].